Pitfalls of using polymerase chain reaction-based assays for JAK2 and CALR exon 9 variant testing in myeloproliferative neoplasms: Knowing when to go the extra mile!

Krishnamurthy, Kritika; Chai, Jiani; Wang, Yanhua; Naeem, Rizwan; Goldstein, D Yitzchak

Krishnamurthy, Kritika; Chai, Jiani; Wang, Yanhua; Naeem, Rizwan; Goldstein, D Yitzchak.

Afiliación

Krishnamurthy K; Department of Pathology, Montefiore Medical Center, Bronx, NY, US.
Chai J; Department of Pathology, Montefiore Medical Center, Bronx, NY, US.
Wang Y; Department of Pathology, Montefiore Medical Center, Bronx, NY, US.
Naeem R; Albert Einstein College of Medicine, Bronx, NY, US.
Goldstein DY; Department of Pathology, Montefiore Medical Center, Bronx, NY, US.

Am J Clin Pathol ; 161(2): 155-161, 2024 Feb 01.

Article en En | MEDLINE | ID: mdl-37788380

Asunto(s)

Trastornos Mieloproliferativos; Neoplasias; Humanos; Calreticulina/genética; Calreticulina/metabolismo; Trastornos Mieloproliferativos/diagnóstico; Trastornos Mieloproliferativos/genética; Mutación; Exones/genética; Janus Quinasa 2/genética; Janus Quinasa 2/metabolismo; Reacción en Cadena de la Polimerasa

Palabras clave

CALR exon 9 variants; JAK2 V617F; PCR-based testing; germline vs somatic; myeloproliferative neoplasm

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Mieloproliferativos / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Am J Clin Pathol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google